Abstract
PDA is accounts for 5-10% of all congenital heart disease. If detected in adulthood usually present with LV volume overload or Eisenmenger syndrome. If, there is no contraindication for closure and anatomically be suitable, trans-catheter device closure is the preferred option. The success rate is high and actually residual shunt would disappear within weeks to months.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Carlgren LE. The incidence of congenital heart disease in children born in Gothenburg 1941–1950. Br Heart J. 1959;21:40–50.
2018-AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e698–800. https://doi.org/10.1161/CIR.0000000000000603.
Rao PS. Summary and comparison of patent ductus arteriosus closure methods. In: Rao PS, Kern MJ, editors. Catheter based devices for the treatment of non-coronary cardiovascular disease in adults and children. Philadelphia, PA: Lippincott Williams & Wilkins; 2003. p. 219–28.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag London Ltd., part of Springer Nature
About this chapter
Cite this chapter
Firouzi, A., Hosseini, Z. (2021). Transcatheter Patent Ductus Arteriosus (PDA) Device Closure. In: Maleki, M., Alizadehasl, A. (eds) Case-Based Clinical Cardiology. Springer, London. https://doi.org/10.1007/978-1-4471-7496-7_65
Download citation
DOI: https://doi.org/10.1007/978-1-4471-7496-7_65
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-7495-0
Online ISBN: 978-1-4471-7496-7
eBook Packages: MedicineMedicine (R0)